CERO Cero Therapeutics Holdings, Inc.
Fundamentals / CIK 0001870404 / USDCero Therapeutics Holdings, Inc. reported $1.83M in total assets and a net loss of $7.44M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open CERO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-- Operating profit
-
Net Income FY 2025-$7.44M GAAP bottom line
-
Diluted EPS FY 2025-$0.01 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$456K Total debt: $669K
Annual revenue and net income
3 fiscal years (2022 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Research & Development | -- | $5.29M | -- |
| Total Operating Expenses | -- | $7.68M | $2.91M |
| Operating Income | -- | -$7.68M | -$2.91M |
| Interest Income | -- | $492K | $2.84M |
| Interest Expense | -- | -$138K | -- |
| Income Before Tax | -$19.92M | -$2.44M | -$69K |
| Income Tax Expense | -- | $95K | $599K |
| Net Income | -$19.92M | -$7.29M | -$668K |
| Basic EPS | -- | -$4,994,560,000.00 | -- |
| Diluted EPS | -- | -$4,994,560,000.00 | -- |
| Basic Shares Outstanding | -- | 0 | -- |
| Diluted Shares Outstanding | -- | 0 | -- |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.97M | $1.74M | $2.34M | -- | $2.39M | $2.75M | $2.91M | $1.77M |
| Total Operating Expenses | $3.19M | $3.85M | $4.85M | -- | $4.36M | $4.72M | $4.95M | $4.40M |
| Operating Income | -$3.19M | -$3.85M | -$4.85M | -- | -$4.36M | -$4.72M | -$4.95M | -$4.40M |
| EBITDA | -$3.14M | -$3.79M | -- | -- | -$4.29M | -$4.65M | -$4.87M | -$4.29M |
| Interest Income | $1.1K | $1.0K | $3.1K | -- | $5.9K | $14K | $850 | -- |
| Interest Expense | $918K | $690K | $166K | -- | -- | -- | -- | -- |
| Net Income | $4.02M | -$1.03M | -$5.89M | -$4.54M | -$4.86M | -$5.42M | -$5.11M | -$4.23M |
| Basic EPS | $0.06 | -$0.70 | -$0.20 | -- | -$9.10 | -$61.71 | -$31.82 | -$170.22 |
| Diluted EPS | $0.00 | -$0.70 | -$0.20 | -- | -$9.10 | -$61.71 | -$31.82 | -$170.22 |
| Basic Shares Outstanding | 72.8M | 42.2M | 28.8M | -- | 1.3M | 488.1K | 171.4K | 24.8K |
| Diluted Shares Outstanding | 1.09B | 42.2M | 28.8M | -- | 1.3M | 488.1K | 171.4K | 24.8K |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & Cash Equivalents | $1.70M | $1.88M | $97K | $476K | $1.10M |
| Cash & Short-Term Investments | $1.70M | $1.88M | $97K | $476K | $1.10M |
| Total Current Assets | $2.73M | $3.71M | $1.97M | $42.37M | $1.36M |
| Property, Plant & Equipment, Net | $246K | $529K | $967K | -- | -- |
| Total Non-Current Assets | $907K | $2.49M | $3.16M | $0 | $178.7M |
| Total Assets | $3.64M | $6.21M | $5.13M | $42.37M | $180.1M |
| Accounts Payable | $7.58M | $4.51M | $1.67M | -- | $14K |
| Other Current Liabilities | $692 | $692 | -- | -- | -- |
| Total Current Liabilities | $9.09M | $7.40M | $3.51M | $30.75M | $98K |
| Deferred Revenue (Non-Current) | -- | -- | $9.15M | $9.15M | -- |
| Total Non-Current Liabilities | $0 | $699K | $1.58M | $9.15M | $9.15M |
| Total Liabilities | $9.09M | $8.10M | $5.08M | $39.90M | $9.25M |
| Total Debt (incl. Leases) | $1.04M | $1.58M | $2.34M | -- | -- |
| Common Stock | -- | -- | $1 | $88 | -- |
| Retained Earnings | -$90.84M | -$70.92M | -$43.09M | -$11.00M | -- |
| Total Stockholders' Equity | -$5.45M | -$1.89M | -$42.06M | -$11.00M | -$7.67M |
| Total Equity | -$5.45M | -$1.89M | -$42.06M | -$11.00M | -$7.67M |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $456K | $863K | $857.5B | $1.70M | $1.95M | $3.23M | $5.10M | $1.88M |
| Cash & Short-Term Investments | $456K | $863K | $857.5B | $1.70M | $1.95M | $3.23M | $5.10M | $1.88M |
| Total Current Assets | $975K | $1.55M | $1.57M | $2.73M | $2.55M | $4.25M | $5.77M | $3.71M |
| Property, Plant & Equipment, Net | $71K | $126K | $184K | $246K | $313K | $383K | $452K | $529K |
| Total Non-Current Assets | $854K | $352K | $631K | $907K | $1.36M | $1.96M | $2.22M | $2.49M |
| Total Assets | $1.83M | $1.90M | $2.21M | $3.64M | $3.91M | $6.20M | $7.99M | $6.21M |
| Accounts Payable | $7.61M | $8.22M | $7.69M | $7.58M | $7.08M | $6.21M | $6.38M | $4.51M |
| Other Current Liabilities | $692 | $692 | $692 | $692 | -- | -- | -- | $692 |
| Total Current Liabilities | $20.32M | $32.41M | $11.33M | $9.09M | $8.45M | $7.62M | $7.86M | $7.40M |
| Long-Term Debt | -- | -- | $137K | -- | -- | -- | -- | -- |
| Total Non-Current Liabilities | $354K | $0 | $137K | $0 | $0 | $218K | $462K | $699K |
| Total Liabilities | $20.67M | $32.41M | $11.46M | $9.09M | $8.45M | $7.84M | $8.32M | $8.10M |
| Total Debt (incl. Leases) | $669K | $233K | $794K | $1.04M | $931K | $1.15M | $1.37M | $1.58M |
| Retained Earnings | -$93.73M | -$97.75M | -$96.72M | -$90.84M | -$86.30M | -$81.44M | -$76.02M | -$70.92M |
| Total Stockholders' Equity | -$18.84M | -$30.51M | -$9.26M | -$5.45M | -$4.54M | -$1.63M | -$329K | -$1.89M |
| Total Equity | -$18.84M | -$30.51M | -$9.26M | -$5.45M | -$4.54M | -$1.63M | -$329K | -$1.89M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Net Income | $19.90M | -$7.29M | -$668K |
| Stock-Based Compensation | $1.10M | $97K | -- |
| Operating Cash Flow | -$16.10M | -$1.52M | -$1.09M |
| Purchases of Investments | -- | -$178.5M | -- |
| Investing Cash Flow | -- | -$7.94M | $180.8M |
| Common Stock Issued | -- | -- | $0 |
| Share Repurchases | -- | -$33.48M | -$139.4M |
| Dividends Paid | -$127K | -- | -- |
| Financing Cash Flow | -- | -$32.58M | -$138.7M |
| Net Change in Cash | -- | -$42.04M | $41.04M |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$4.00M | $1.00M | $5.90M | -$4.54M | -$4.86M | -$5.42M | -$5.11M | -$4.23M |
| Depreciation & Amortization | $55K | $59K | -- | -- | $69K | $76K | $76K | $114K |
| Stock-Based Compensation | $122K | $1.12M | $1.62M | $260K | $348K | $183K | $305K | -- |
| Operating Cash Flow | -$3.03M | -$7.89M | $2.80M | -- | -- | -- | -- | -- |
| Dividends Paid | -- | -- | -$127K | $0 | $0 | $0 | -$127K | -- |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|
| Return on Assets (ROA) | -547.1% | -142.2% | -1.6% |
| Current Ratio | 0.30x | 0.56x | 1.38x |
| Quick Ratio | 0.19x | 0.03x | 0.02x |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -406.7% | -858.5% | -938.7% | -547.1% | -- | -- | -- | -- |
| Current Ratio | 0.05x | 0.05x | 0.14x | 0.30x | 0.30x | 0.56x | 0.73x | -- |
| Quick Ratio | 0.02x | 0.03x | 75702.43x | 0.19x | 0.23x | 0.42x | 0.65x | -- |